Home/FT/Coronavirus latest: Regeneron to stop enrolling seriously ill Covid patients in antibody trials FT Coronavirus latest: Regeneron to stop enrolling seriously ill Covid patients in antibody trials Financial Times0 Less than a minute Facebook X LinkedIn Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
